<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>921</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11207652</PubmedId>
            <Abstract>Lymphoproliferation of healthy donors was tested against mycobacterial antigens (PPD, Ag85, Ag85 peptides). All PPD responders recognized the secretory antigen Ag85 and the peptide specificity for Ag85B was defined. Peptide 91-108 was recognized by 85% of donors. In addition, all CD4 T cell lines generated from 12 donors against PPD or Ag85 responded to 91-108. When this peptide was used to generate T cell lines, the cells responded also to tuberculins from atypical mycobacterial species. Thus the cross-reactive peptide behaved as quasi-universal. The analysis of TCR-BV gene usage by cell lines showed that most Ag85-specific T cells correspond to 91-108-specific clonotypes. Intracytoplasmic staining of cell lines after phorbol myristate acetate stimulation resulted in dominance of interferon-gamma (IFN-gamma)-IL-4 double-positive cells, whereas antigen stimulation resulted in production of IFN-gamma only. The data show that peptide 91-108 is the major focus of the CD4 response to mycobacterial antigens in peripheral blood mononuclear cells and in T cell lines from PPD responders.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>226-32</ArticlePages>
            <ArticleTitle>Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Valle</LastName>
                    <ForeName>M T</ForeName>
                </Author>
                <Author>
                    <LastName>Megiovanni</LastName>
                    <ForeName>A M</ForeName>
                </Author>
                <Author>
                    <LastName>Merlo</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Li Pira</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Bottone</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Angelini</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Bracci</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Lozzi</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Huygen</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Manca</LastName>
                    <ForeName>F</ForeName>
                </Author>
            </Authors>
            <Affiliations>Immunology Laboratory, San Martino Hospital and Unit of Retroviral Immunology, Advanced Biotechnology Centre, Genoa, Italy.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;CD4 Antigens;Epitopes, T-Lymphocyte;Acyltransferases;antigen 85A, Mycobacterium tuberculosis</ArticleChemicalList>
            <ArticleMeshHeadingsList>Acyltransferases; Antigens, Bacterial(immunology); CD4 Antigens(immunology); CD4-Positive T-Lymphocytes(immunology; microbiology); Cell Differentiation(immunology); Cytotoxicity, Immunologic; Epitopes, T-Lymphocyte(immunology); Humans; Mycobacterium tuberculosis(immunology); Th1 Cells(immunology; microbiology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>123</Volume>
                <Issue>2</Issue>
                <Title>Clinical and experimental immunology</Title>
                <Issn>0009-9104</Issn>
                <MedlineTa>Clin Exp Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Peptide 11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QTYKWETLLTSE</LinearSequence>
                        <StartingPosition>133</StartingPosition>
                        <EndingPosition>144</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 4, Author's communication</LocationOfData>
                <EpitopeId>52668</EpitopeId>
                <ReferenceStartingPosition>93</ReferenceStartingPosition>
                <ReferenceEndingPosition>104</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, and 3</LocationOfData>
                        <TCellId>17793</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 11 (91-108)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GCQTYKWETLLTSELPQW</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>148</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>46</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>41</NumberOfSubjectsResponded>
                            <ResponseFrequency>89.1</ResponseFrequency>
                            <AssayComments>89% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize the peptide GCQTYKWETLLTSELPQW with a SI&gt;2. Truncation analysis of the recognition by PBMCs from 9 subjects demonstrates that the epitope (aa 93-104) is the peptide recognized in all the cases. CD4+ T cell lines derived from PMBCs by stimulation with PPD, Ag85 complex, or the epitope also preferentially recognize the epitope among the truncated peptides.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>17794</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                            </InVitroAdministration>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.  PBMcs were stimulated with peptide 11 (91-108) and IL-2 was added on day 6. Th ecells were also restimulated identically 1 month later and then 3 wks later. After stimulation, the cells were 100% CD4+.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 11</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QTYKWETLLTSE</LinearSequence>
                                        <StartingPosition>133</StartingPosition>
                                        <EndingPosition>144</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The response to the epitope and to the Ag85 complex of an epitope specific-T cell line is comparable to that induced by PPD preparations, either from the source species or from M.tuberculosis, M. avium, M. scrofulaceum, M. marinum and M. fortuitum, even when this epitope has some sequence differences among mycobacterium species (the substitution L100F is the only difference in the source protein sequence between M. bovis BCG and M.tuberculosis). The percentage of IFN-g positive cells in this cell line in response to PPD and to epitope are similar. VB18 is the most commonly used TCR beta chain among the epitope specific T cell line.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FSRPGLPVEYLQVPSPSM</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>58</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>17836</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>18</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17807</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FSRPGLPVEYLQVPSPSM</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>58</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>35.7</ResponseFrequency>
                            <AssayComments>35.7% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 2 out of 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 1 out of 14 lines derived with Ag85 complex also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLQVPSPSMGRDIKVQFQ</LinearSequence>
                        <StartingPosition>50</StartingPosition>
                        <EndingPosition>67</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>74889</EpitopeId>
                <ReferenceStartingPosition>10</ReferenceStartingPosition>
                <ReferenceEndingPosition>27</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17814</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLQVPSPSMGRDIKVQFQ</LinearSequence>
                                        <StartingPosition>50</StartingPosition>
                                        <EndingPosition>67</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 3 out of 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD also recognize the peptide, while none of the cells lines derived by stimulation with Ag85 complex do.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GRDIKVQFQSGGNNSPAV</LinearSequence>
                        <StartingPosition>59</StartingPosition>
                        <EndingPosition>76</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>22008</EpitopeId>
                <ReferenceStartingPosition>19</ReferenceStartingPosition>
                <ReferenceEndingPosition>36</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17815</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 3</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GRDIKVQFQSGGNNSPAV</LinearSequence>
                                        <StartingPosition>59</StartingPosition>
                                        <EndingPosition>76</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>42.9</ResponseFrequency>
                            <AssayComments>42.9% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 4 out of 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 3 out of 14 lines derived with Ag85 also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SGGNNSPAVYLLDGLRAQ</LinearSequence>
                        <StartingPosition>68</StartingPosition>
                        <EndingPosition>85</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>58051</EpitopeId>
                <ReferenceStartingPosition>28</ReferenceStartingPosition>
                <ReferenceEndingPosition>45</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17981</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGGNNSPAVYLLDGLRAQ</LinearSequence>
                                        <StartingPosition>68</StartingPosition>
                                        <EndingPosition>85</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with PPD do, while 1 out of 14 derived by stimulation with Ag85 recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLLDGLRAQDDYNGWDIN</LinearSequence>
                        <StartingPosition>77</StartingPosition>
                        <EndingPosition>94</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>74769</EpitopeId>
                <ReferenceStartingPosition>37</ReferenceStartingPosition>
                <ReferenceEndingPosition>54</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17983</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 5</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLLDGLRAQDDYNGWDIN</LinearSequence>
                                        <StartingPosition>77</StartingPosition>
                                        <EndingPosition>94</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>14.3</ResponseFrequency>
                            <AssayComments>14.3% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with PPD do, while 1 of 14 derived by stimulation with Ag85 recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DDYNGWDINTPAFEWYYQ</LinearSequence>
                        <StartingPosition>86</StartingPosition>
                        <EndingPosition>103</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>7894</EpitopeId>
                <ReferenceStartingPosition>46</ReferenceStartingPosition>
                <ReferenceEndingPosition>63</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17984</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DDYNGWDINTPAFEWYYQ</LinearSequence>
                                        <StartingPosition>86</StartingPosition>
                                        <EndingPosition>103</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>None of the 14 healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide, and none of the CD4+ T cell lines derived from PMBCs by stimulation with PPD or with Ag85 do either.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TPAFEWYYQSGLSIVMPV</LinearSequence>
                        <StartingPosition>95</StartingPosition>
                        <EndingPosition>112</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>65499</EpitopeId>
                <ReferenceStartingPosition>55</ReferenceStartingPosition>
                <ReferenceEndingPosition>72</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17985</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 7</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TPAFEWYYQSGLSIVMPV</LinearSequence>
                                        <StartingPosition>95</StartingPosition>
                                        <EndingPosition>112</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>8</NumberOfSubjectsResponded>
                            <ResponseFrequency>57.1</ResponseFrequency>
                            <AssayComments>57.1% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, and 2 of 12 of those derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SGLSIVMPVGGQSSFYSD</LinearSequence>
                        <StartingPosition>104</StartingPosition>
                        <EndingPosition>121</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>58124</EpitopeId>
                <ReferenceStartingPosition>64</ReferenceStartingPosition>
                <ReferenceEndingPosition>81</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17987</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 8</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGLSIVMPVGGQSSFYSD</LinearSequence>
                                        <StartingPosition>104</StartingPosition>
                                        <EndingPosition>121</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, and 3 of 12 of those derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GGQSSFYSDWYSPACGKA</LinearSequence>
                        <StartingPosition>113</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>19989</EpitopeId>
                <ReferenceStartingPosition>73</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>17988</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 9</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGQSSFYSDWYSPACGKA</LinearSequence>
                                        <StartingPosition>113</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>7.1</ResponseFrequency>
                            <AssayComments>7.1% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WYSPACGKAGCQTYKWET</LinearSequence>
                        <StartingPosition>122</StartingPosition>
                        <EndingPosition>139</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>73294</EpitopeId>
                <ReferenceStartingPosition>82</ReferenceStartingPosition>
                <ReferenceEndingPosition>99</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18048</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 10</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WYSPACGKAGCQTYKWET</LinearSequence>
                                        <StartingPosition>122</StartingPosition>
                                        <EndingPosition>139</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, and 4 of 12 of those derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLTSELPQWLSANRAVKP</LinearSequence>
                        <StartingPosition>140</StartingPosition>
                        <EndingPosition>157</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>37874</EpitopeId>
                <ReferenceStartingPosition>100</ReferenceStartingPosition>
                <ReferenceEndingPosition>117</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18049</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 12</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLTSELPQWLSANRAVKP</LinearSequence>
                                        <StartingPosition>140</StartingPosition>
                                        <EndingPosition>157</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>7.1</ResponseFrequency>
                            <AssayComments>7.1% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 1 in 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 1 out of 14 lines derived with Ag85 also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSMAGSSAMILAAYHPQQ</LinearSequence>
                        <StartingPosition>165</StartingPosition>
                        <EndingPosition>182</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>39498</EpitopeId>
                <ReferenceStartingPosition>127</ReferenceStartingPosition>
                <ReferenceEndingPosition>144</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18050</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 15</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSMAGSSAMILAAYHPQQ</LinearSequence>
                                        <StartingPosition>165</StartingPosition>
                                        <EndingPosition>182</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, and 1 of 12 of those derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILAAYHPQQFIYAGSLSA</LinearSequence>
                        <StartingPosition>174</StartingPosition>
                        <EndingPosition>191</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>26949</EpitopeId>
                <ReferenceStartingPosition>136</ReferenceStartingPosition>
                <ReferenceEndingPosition>153</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18051</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 16</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILAAYHPQQFIYAGSLSA</LinearSequence>
                                        <StartingPosition>174</StartingPosition>
                                        <EndingPosition>191</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>14.3</ResponseFrequency>
                            <AssayComments>14.3% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with PPD do, and 3 of 14 of those derived by stimulation with Ag85 recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FIYAGSLSALLDPSQGMG</LinearSequence>
                        <StartingPosition>183</StartingPosition>
                        <EndingPosition>200</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>16334</EpitopeId>
                <ReferenceStartingPosition>145</ReferenceStartingPosition>
                <ReferenceEndingPosition>162</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18052</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 17</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FIYAGSLSALLDPSQGMG</LinearSequence>
                                        <StartingPosition>183</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>14.3</ResponseFrequency>
                            <AssayComments>14.2% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 1 in 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 2 out of 14 lines derived with Ag85 also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLDPSQGMGLIGLAMGDA</LinearSequence>
                        <StartingPosition>192</StartingPosition>
                        <EndingPosition>209</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>37173</EpitopeId>
                <ReferenceStartingPosition>154</ReferenceStartingPosition>
                <ReferenceEndingPosition>171</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18053</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 18</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLDPSQGMGLIGLAMGDA</LinearSequence>
                                        <StartingPosition>192</StartingPosition>
                                        <EndingPosition>209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>35.7</ResponseFrequency>
                            <AssayComments>35.7% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LIGLAMGDAGGYKAADMW</LinearSequence>
                        <StartingPosition>201</StartingPosition>
                        <EndingPosition>218</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>36536</EpitopeId>
                <ReferenceStartingPosition>163</ReferenceStartingPosition>
                <ReferenceEndingPosition>180</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18054</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 19</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LIGLAMGDAGGYKAADMW</LinearSequence>
                                        <StartingPosition>201</StartingPosition>
                                        <EndingPosition>218</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GGYKAADMWGPSSDPAWE</LinearSequence>
                        <StartingPosition>210</StartingPosition>
                        <EndingPosition>227</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>20101</EpitopeId>
                <ReferenceStartingPosition>172</ReferenceStartingPosition>
                <ReferenceEndingPosition>189</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18055</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGYKAADMWGPSSDPAWE</LinearSequence>
                                        <StartingPosition>210</StartingPosition>
                                        <EndingPosition>227</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>42.9</ResponseFrequency>
                            <AssayComments>42.9% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, and 1 of 12 of those derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 21</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPSSDPAWERNDPTQQIP</LinearSequence>
                        <StartingPosition>219</StartingPosition>
                        <EndingPosition>236</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>21796</EpitopeId>
                <ReferenceStartingPosition>181</ReferenceStartingPosition>
                <ReferenceEndingPosition>198</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18057</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 21</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GPSSDPAWERNDPTQQIP</LinearSequence>
                                        <StartingPosition>219</StartingPosition>
                                        <EndingPosition>236</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 1 in 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 1 out of 14 lines derived with Ag85 also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 23</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KLVANNTRLWVYCGNGTP</LinearSequence>
                        <StartingPosition>237</StartingPosition>
                        <EndingPosition>254</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>32215</EpitopeId>
                <ReferenceStartingPosition>199</ReferenceStartingPosition>
                <ReferenceEndingPosition>216</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18058</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 23</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KLVANNTRLWVYCGNGTP</LinearSequence>
                                        <StartingPosition>237</StartingPosition>
                                        <EndingPosition>254</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 1 in 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 1 out of 14 lines derived with Ag85 also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WVYCGNGTPNELGGANIP</LinearSequence>
                        <StartingPosition>246</StartingPosition>
                        <EndingPosition>263</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>73235</EpitopeId>
                <ReferenceStartingPosition>208</ReferenceStartingPosition>
                <ReferenceEndingPosition>225</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18059</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 24</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WVYCGNGTPNELGGANIP</LinearSequence>
                                        <StartingPosition>246</StartingPosition>
                                        <EndingPosition>263</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, while 1 of 12 derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NELGGANIPAEFLENFVR</LinearSequence>
                        <StartingPosition>255</StartingPosition>
                        <EndingPosition>272</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>43670</EpitopeId>
                <ReferenceStartingPosition>217</ReferenceStartingPosition>
                <ReferenceEndingPosition>234</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18064</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 25</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NELGGANIPAEFLENFVR</LinearSequence>
                                        <StartingPosition>255</StartingPosition>
                                        <EndingPosition>272</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>14.3</ResponseFrequency>
                            <AssayComments>14.3% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, while 1 of 12 derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 26</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AEFLENFVRSSNLKFQDA</LinearSequence>
                        <StartingPosition>264</StartingPosition>
                        <EndingPosition>281</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>905</EpitopeId>
                <ReferenceStartingPosition>226</ReferenceStartingPosition>
                <ReferenceEndingPosition>243</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18065</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 26</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AEFLENFVRSSNLKFQDA</LinearSequence>
                                        <StartingPosition>264</StartingPosition>
                                        <EndingPosition>281</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>35.7</ResponseFrequency>
                            <AssayComments>35.7% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, while 1 of 12 derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 27</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SSNLKFQDAYKPAGGHNA</LinearSequence>
                        <StartingPosition>273</StartingPosition>
                        <EndingPosition>290</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>61240</EpitopeId>
                <ReferenceStartingPosition>235</ReferenceStartingPosition>
                <ReferenceEndingPosition>252</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18066</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 27</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SSNLKFQDAYKPAGGHNA</LinearSequence>
                                        <StartingPosition>273</StartingPosition>
                                        <EndingPosition>290</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 do, while 1 of 12 derived by stimulation with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 28</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YKPAGGHNAVFNFPPNGT</LinearSequence>
                        <StartingPosition>282</StartingPosition>
                        <EndingPosition>299</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>74486</EpitopeId>
                <ReferenceStartingPosition>244</ReferenceStartingPosition>
                <ReferenceEndingPosition>261</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18067</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 28</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YKPAGGHNAVFNFPPNGT</LinearSequence>
                                        <StartingPosition>282</StartingPosition>
                                        <EndingPosition>299</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>21.4</ResponseFrequency>
                            <AssayComments>21.4% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 29</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VFNFPPNGTHSWEYWGAQ</LinearSequence>
                        <StartingPosition>291</StartingPosition>
                        <EndingPosition>308</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>68529</EpitopeId>
                <ReferenceStartingPosition>253</ReferenceStartingPosition>
                <ReferenceEndingPosition>270</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18068</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 29</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VFNFPPNGTHSWEYWGAQ</LinearSequence>
                                        <StartingPosition>291</StartingPosition>
                                        <EndingPosition>308</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>7.1</ResponseFrequency>
                            <AssayComments>7.1% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 30</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HSWEYWGAQLNAMKGDLQ</LinearSequence>
                        <StartingPosition>300</StartingPosition>
                        <EndingPosition>317</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>24876</EpitopeId>
                <ReferenceStartingPosition>262</ReferenceStartingPosition>
                <ReferenceEndingPosition>279</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18070</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 30</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HSWEYWGAQLNAMKGDLQ</LinearSequence>
                                        <StartingPosition>300</StartingPosition>
                                        <EndingPosition>317</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>7.1</ResponseFrequency>
                            <AssayComments>7.1% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. 1 out of 12 CD4+ T cell lines derived from PMBCs by stimulation with PPD and 1 out of 14 lines derived with Ag85 complex also recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 31</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LNAMKGDLQSSLGAG</LinearSequence>
                        <StartingPosition>309</StartingPosition>
                        <EndingPosition>323</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA25359.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>33892</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Author's communication</LocationOfData>
                <EpitopeId>38169</EpitopeId>
                <ReferenceStartingPosition>271</ReferenceStartingPosition>
                <ReferenceEndingPosition>285</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Source protein and 85A and 85C proteins conform the Ag85 complex. Genbank entry includes the 40aa signal peptide not included in this study, so that different positions are indicated for the epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>18071</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The donors are PPD+ but otherwise healthy. No information on the origin of the reactivity is provided.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>304</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Biological process measured</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 31</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LNAMKGDLQSSLGAG</LinearSequence>
                                        <StartingPosition>309</StartingPosition>
                                        <EndingPosition>323</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA25359.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>33892</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>28.6</ResponseFrequency>
                            <AssayComments>28.6% of healthy Purified Protein Derivative positive ( PPD+) individuals studied recognize this peptide with a SI&gt;2. None of the CD4+ T cell lines derived from PMBCs by stimulation with Ag85 or with PPD recognize the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

